145 related articles for article (PubMed ID: 33163847)
1. Nearly Half of
Diessner BJ; Pankratz N; Hooten AJ; Mirabello L; Sarver AL; Mills LJ; Malkin D; Kelley AC; Spector LG
JCO Precis Oncol; 2020; 4():. PubMed ID: 33163847
[TBL] [Abstract][Full Text] [Related]
2. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
3. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Mouren A; Chansavang A; Hamzaoui N; Srikaran A; Laurent-Puig P; Marisa L; De Percin S; Lupo A; Larousserie F; Blons H; L'Haridon A; Burnichon N; Pasmant E; Tlemsani C
Fam Cancer; 2024 May; ():. PubMed ID: 38763984
[TBL] [Abstract][Full Text] [Related]
4. Resolving inherited and
Brozou T; Yasin L; Brandes D; Picard D; Walter C; Varghese J; Dugas M; Fischer U; Borkhardt A; Haas OA
Front Pediatr; 2022; 10():1080347. PubMed ID: 36824296
[TBL] [Abstract][Full Text] [Related]
5. Whole-Exome Sequencing in Family Trios Reveals De Novo Mutations Associated with Type 1 Diabetes Mellitus.
Mousa M; Albarguthi S; Albreiki M; Farooq Z; Sajid S; El Hajj Chehadeh S; ElBait GD; Tay G; Deeb AA; Alsafar H
Biology (Basel); 2023 Mar; 12(3):. PubMed ID: 36979105
[TBL] [Abstract][Full Text] [Related]
6. Rare variants and de novo variants in mesial temporal lobe epilepsy with hippocampal sclerosis.
Wong JKL; Gui H; Kwok M; Ng PW; Lui CHT; Baum L; Sham PC; Kwan P; Cherny SS
Neurol Genet; 2018 Jun; 4(3):e245. PubMed ID: 29904720
[TBL] [Abstract][Full Text] [Related]
7. Recurrent de novo WFS1 pathogenic variants in Chinese sporadic patients with nonsyndromic sensorineural hearing loss.
Guan J; Wang H; Lan L; Wu Y; Chen G; Zhao C; Wang D; Wang Q
Mol Genet Genomic Med; 2020 Aug; 8(8):e1367. PubMed ID: 32567228
[TBL] [Abstract][Full Text] [Related]
8. Germline pathogenic variants in 786 neuroblastoma patients.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani N; Dymek M; Desai H; Hausler R; ; ; ; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
medRxiv; 2023 Jan; ():. PubMed ID: 36747619
[TBL] [Abstract][Full Text] [Related]
9. Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer Therapy.
Schneider BP; Stout LA; Philips S; Schroeder C; Scott SF; Hunter C; Kassem N; Kiel PJ; Radovich M
JCO Precis Oncol; 2020 Nov; 4():1109-1121. PubMed ID: 35050776
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
Parsons DW; Roy A; Yang Y; Wang T; Scollon S; Bergstrom K; Kerstein RA; Gutierrez S; Petersen AK; Bavle A; Lin FY; López-Terrada DH; Monzon FA; Hicks MJ; Eldin KW; Quintanilla NM; Adesina AM; Mohila CA; Whitehead W; Jea A; Vasudevan SA; Nuchtern JG; Ramamurthy U; McGuire AL; Hilsenbeck SG; Reid JG; Muzny DM; Wheeler DA; Berg SL; Chintagumpala MM; Eng CM; Gibbs RA; Plon SE
JAMA Oncol; 2016 May; 2(5):616-624. PubMed ID: 26822237
[TBL] [Abstract][Full Text] [Related]
11. Using case-parent trios to look for rare de novo genetic variants in adult-onset neurodegenerative diseases.
Pamphlett R; Morahan JM; Yu B
J Neurosci Methods; 2011 Apr; 197(2):297-301. PubMed ID: 21392527
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.
van Lint FHM; Murray B; Tichnell C; Zwart R; Amat N; Lekanne Deprez RH; Dittmann S; Stallmeyer B; Calkins H; van der Smagt JJ; van den Wijngaard A; Dooijes D; van der Zwaag PA; Schulze-Bahr E; Judge DP; Jongbloed JDH; van Tintelen JP; James CA
Circ Genom Precis Med; 2019 Aug; 12(8):e002467. PubMed ID: 31386562
[TBL] [Abstract][Full Text] [Related]
14. Analysis of
Franaszczyk M; Truszkowska G; Chmielewski P; Rydzanicz M; Kosinska J; Rywik T; Biernacka A; Spiewak M; Kostrzewa G; Stepien-Wojno M; Stawinski P; Bilinska M; Krajewski P; Zielinski T; Lutynska A; Bilinska ZT; Ploski R
J Clin Med; 2020 Jan; 9(2):. PubMed ID: 32013205
[TBL] [Abstract][Full Text] [Related]
15. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease.
Ku CS; Polychronakos C; Tan EK; Naidoo N; Pawitan Y; Roukos DH; Mort M; Cooper DN
Mol Psychiatry; 2013 Feb; 18(2):141-53. PubMed ID: 22641181
[TBL] [Abstract][Full Text] [Related]
16. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
Mol Autism; 2017; 8():14. PubMed ID: 28344757
[TBL] [Abstract][Full Text] [Related]
17. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.
Qian M; Cao X; Devidas M; Yang W; Cheng C; Dai Y; Carroll A; Heerema NA; Zhang H; Moriyama T; Gastier-Foster JM; Xu H; Raetz E; Larsen E; Winick N; Bowman WP; Martin PL; Mardis ER; Fulton R; Zambetti G; Borowitz M; Wood B; Nichols KE; Carroll WL; Pui CH; Mullighan CG; Evans WE; Hunger SP; Relling MV; Loh ML; Yang JJ
J Clin Oncol; 2018 Feb; 36(6):591-599. PubMed ID: 29300620
[TBL] [Abstract][Full Text] [Related]
18. Family trio-based sequencing in 404 sporadic bilateral hearing loss patients discovers recessive and De novo genetic variants in multiple ways.
Guan J; Li J; Chen G; Shi T; Lan L; Wu X; Zhao C; Wang D; Wang H; Wang Q
Eur J Med Genet; 2021 Oct; 64(10):104311. PubMed ID: 34416374
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterisation of de novo germline structural variants in two commercial pig lines using trio-based whole genome sequencing.
Steensma MJ; Lee YL; Bouwman AC; Pita Barros C; Derks MFL; Bink MCAM; Harlizius B; Huisman AE; Crooijmans RPMA; Groenen MAM; Mulder HA; Rochus CM
BMC Genomics; 2023 Apr; 24(1):208. PubMed ID: 37072725
[TBL] [Abstract][Full Text] [Related]
20. Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma.
Shaul E; Roth M; Lo Y; Geller DS; Hoang B; Yang R; Malkin D; Gorlick R; Gill J
Cancer; 2018 Mar; 124(6):1242-1250. PubMed ID: 29313943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
